| scholarly article | Q13442814 |
| P50 | author | Geoffrey Roberts | Q56804810 |
| Frank Reimann | Q61094331 | ||
| Pierre Larraufie | Q63379583 | ||
| P2093 | author name string | Giles S H Yeo | |
| Richard H Hardwick | |||
| Fiona M Gribble | |||
| David C Hornigold | |||
| Richard G Kay | |||
| Peter Ravn | |||
| Joyce Li | |||
| Andrew Leiter | |||
| Anne K McGavigan | |||
| Audrey Melvin | |||
| Emma K Biggs | |||
| Kathleen Davy | |||
| P2860 | cites work | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 |
| STAR: ultrafast universal RNA-seq aligner | Q29615052 | ||
| TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice | Q33907979 | ||
| Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus | Q34366918 | ||
| MARIS: method for analyzing RNA following intracellular sorting | Q35110660 | ||
| Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus | Q35824086 | ||
| Postprandial Hypoglycemia in Children after Gastric Surgery: Clinical Characterization and Pathophysiology | Q36520647 | ||
| Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats | Q36528419 | ||
| Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency | Q37015063 | ||
| Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. | Q37110621 | ||
| Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. | Q37620091 | ||
| GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents | Q37629291 | ||
| Food selection and taste changes in humans after Roux-en-Y gastric bypass surgery: a direct-measures approach | Q37988244 | ||
| Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery | Q38060843 | ||
| GLP-1 effects on islets: hormonal, neuronal, or paracrine? | Q38123791 | ||
| Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium | Q38600658 | ||
| β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy. | Q39512675 | ||
| Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells. | Q40545186 | ||
| Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. | Q41710424 | ||
| Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report | Q41832470 | ||
| Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine | Q42174256 | ||
| Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum | Q42488494 | ||
| Liquid chromatography/mass spectrometry based detection and semi-quantitative analysis of INSL5 in human and murine tissues | Q47149058 | ||
| Development and characterisation of a novel glucagon like peptide-1 receptor antibody | Q47366967 | ||
| Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia | Q47607423 | ||
| Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task | Q47971294 | ||
| Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome | Q48132866 | ||
| Incretin hormones: Their role in health and disease | Q48175166 | ||
| The Role of GLP-1 in the Metabolic Success of Bariatric Surgery | Q50080451 | ||
| Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it? | Q50117726 | ||
| Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals. | Q50788463 | ||
| The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice. | Q51091690 | ||
| EJE PRIZE 2018: A gut feeling about glucagon. | Q52573435 | ||
| Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. | Q53589377 | ||
| Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. | Q54156279 | ||
| Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy | Q58449247 | ||
| Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells. | Q64944794 | ||
| Taste and odor preferences following Roux-en-Y surgery in humans. | Q64980972 | ||
| Accurate measurement of intestinal transit in the rat | Q71069600 | ||
| Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans | Q83139768 | ||
| Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males | Q85328750 | ||
| Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery | Q88083879 | ||
| Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor | Q88669521 | ||
| Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies | Q90909445 | ||
| P4510 | describes a project that uses | RStudio | Q4798119 |
| DESeq2 | Q113018293 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| bariatric surgery | Q357503 | ||
| transcriptomics | Q28946449 | ||
| glp-1 | Q29698407 | ||
| Peptidomics | Q50815502 | ||
| P304 | page(s) | 1399-1408.e6 | |
| P577 | publication date | 2019-02-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery | |
| P478 | volume | 26 |
| Q91597663 | Balancing glucose levels after bariatric surgery - an important role for GLP1 |
| Q91012100 | Characterisation of proguanylin expressing cells in the intestine - evidence for constitutive luminal secretion |
| Q64286442 | Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones |
| Q89829931 | Gastric Bypass in Female Rats Lowers Concentrated Sugar Solution Intake and Preference Without Affecting Brief Access Licking After Long-Term Sugar Exposure |
| Q89584673 | PYY, a Therapeutic Option for Type 2 Diabetes? |
| Q90884684 | Preoperative liking and wanting for sweet beverages as predictors of body weight loss after Roux-en-Y gastric bypass and sleeve gastrectomy |
| Q92981380 | Roux-en-Y gastric bypass surgery progressively alters radiologic measures of hypothalamic inflammation in obese patients |
| Q89518863 | Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine |
| Q92610075 | The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids |
| Q100512413 | Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity |
Search more.